Polaris

IPO

首頁 - Polaris Group

Public · Taipei, Taiwan · Founded 2006 · $10.0M raised

Headquarters
Taipei
Founded
2006
Business Model
B2B
Total Funding
$10.0M
Last Round
$10.0M Series ASep 2016
Rounds
1
Type
Public

About

Polaris Group develops novel cancer therapies centered on metabolic vulnerabilities in tumor cells. Its lead biologic, Pegargiminase, is in late-stage clinical development across multiple cancer indications and works by depriving susceptible cancer cells of plasma-borne arginine. The group participates across the drug-development lifecycle through structure-based design, clinical studies, biologics manufacturing, and contract development and manufacturing operations in several international locations.

Summary

Polaris is a Biotech company based in Taipei, Taiwan, founded in 2006. It has raised $10.0M in total across 1 round, most recently a $10.0M Series A round in Sep 2016. Investors include SAIF Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ASep 2016
$10.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Polaris on Indexed.vc
<a href="https://indexed.vc/companies/polaris"><img src="https://indexed.vc/api/badge/company/polaris" alt="Polaris on Indexed.vc" width="260" height="76" /></a>